ENGN (enGene Holdings Inc.) Utang jangka cendhak marang modal
This GURU.Markets price chart for enGene Holdings Inc. (ENGN) reflects a debt-to-equity ratio of 0.00. The firm's technological advantage is secured by patents for mucosal drug delivery methods. The business model relies on developing non-viral, unconventional therapies for bladder cancer, while human capital is sustained by attracting leading immunologists through a long-term incentive system.
Rincian analitis perusahaan enGene Holdings Inc.
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal enGene Holdings Inc.|ENGN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas enGene|ENGN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku enGene Holdings Inc|ENGN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan enGene|Likuiditas cepet engene.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:enGene Bio
Developing a unique non-viral gene delivery platform requires significant investment in R&D and FDA certification. Analyzing the short-term debt-to-market cap chart, an investor assesses the proportion of current liabilities relative to the company's equity. This metric measures the business's dependence on rapid refinancing and the risk of liquidity loss. The stability of this ratio confirms the financial resilience of enGene Holdings Inc. (ENGN) within the highly competitive biopharmaceutical sector.
Pesaing utama
Utang jangka cendhak marang modal ARGX|BNTX (BioNTech Pharma) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal ABVX (Abivax Pharma)|Utang jangka cendhak marang modal admabiologics.com ADMA|PTGX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Grifols Biemat|ADPT (Adaptive Biotechnologies) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal celldex.com|Rasio utang jangka cendhak marang ekuitas AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VERA (Vera Pharma)|Koefisien utang jangka cendhak marang modal Dianthus Corp (DNTH)|PHVS - Utang jangka cendhak marang ekuitas|AbCellera Biologics Inc (ABCL) - Rasio utang jangka cendhak marang ekuitas|Tourmaline Bio (TRML) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Precigen Inc|Rasio utang jangka cendhak marang ekuitas PHAR|Utang jangka cendhak marang modal Nektar Corp|Utang jangka cendhak marang ekuitas Upstream Bio Inc (UPB)|zenasbio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Kewajiban jangka cendhak marang modal|KalVista Pharmaceuticals Inc - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Septerna Pharma|Pieris Pharmaceuticals (PVLA) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal SVRA|RIGL (Rigel Pharmaceuticals, Inc.) - Utang jangka cendhak marang modal|ANAB - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal ATXS|RAPT - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Aerovate Therapeutics JBIO|ACRS: Rasio utang jangka cendhak marang modal|Kyverna Therapeutics, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Rasio utang jangka cendhak marang ekuitas|Ventyx Biosciences, Inc - Rasio tanggungan utang jangka cendhak marang modal|THTX (Theratechnologies Inc.) - Utang jangka cendhak marang modal|AVTX: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Climb Bio, Inc. CLYM|zurabio.com - Utang jangka cendhak marang ekuitas|aTyr Pharma, Inc. - Utang jangka cendhak marang modal|ADAG (Adagene) - Rasio utang jangka cendhak marang modal|IMA: Utang jangka cendhak marang modal|STTK - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Equillium Inc|Rasio utang jangka cendhak marang modal CNTB (Connect Pharma)|Utang jangka cendhak marang modal IMUX|atarabio.com (ATRA) - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas InflaRx IFRX|Koefisien utang jangka cendhak marang modal X4 Pharmaceuticals Inc. (XFOR)|ACET: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal CELU (Celularity Inc.)|INMB: Utang jangka cendhak marang modal|BRNS - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Kezar Life Sciences, Inc.|Rasio utang jangka cendhak marang modal SABS (SAB Biotherapeutics Inc.)|Utang jangka cendhak marang modal AKTX|Rasio utang jangka cendhak marang ekuitas enlivex.com ENLV|Q32 Bio - Rasio utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal geovax.com (GOVX)|Edesa Biotech - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal iBio Inc|carismatx.com (CARM) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal XTLB|BOLT (Bolt Biotherapeutics Inc.) - Utang jangka cendhak marang modal|HCWB - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Aptevo Therapeutics (APVO)|aimimmuno.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Kewajiban jangka cendhak marang ekuitas|XORTX Therapeutics Inc. - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal HIND (reshapelifesciences.com)|REVB: Utang jangka cendhak marang modal|Indaptus Therapeutics Inc (INDP) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Scinai|CALI: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Affimed (AFMD)|Rasio utang jangka cendhak marang ekuitas allakos.com ALLK|Utang jangka cendhak marang modal HOOK (HOOKIPA Pharma)|Utang jangka cendhak marang modal IGM Biosciences Inc. IGMS|ITOS: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal OCEA (Ocean Biomedical Corp)|TCBP: Utang jangka cendhak marang modal|THRD - Koefisien utang jangka cendhak marang modal